116 filings
Page 3 of 6
424B5
zfial8gcad8 z6
16 May 23
Prospectus supplement for primary offering
5:19pm
AW
gjw cegbi
16 May 23
Withdrawal of amendment
1:19pm
S-3/A
6ugc2ce
15 May 23
Shelf registration (amended)
6:01pm
CORRESP
lpdrfepkcne3lnjn
15 May 23
Correspondence with SEC
12:00am
CORRESP
6vylkpd
15 May 23
Correspondence with SEC
12:00am
8-K
pn9ixd 1e9
10 May 23
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:16am
CORRESP
oaqj lup8xknfu0
10 May 23
Correspondence with SEC
12:00am
CORRESP
c6jynva6
10 May 23
Correspondence with SEC
12:00am
8-K
2oe9ock
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
ARS
0j7ddm
25 Apr 23
Annual report to shareholders
8:01am
DEFA14A
z3lh28dr1x5mzhexs0
25 Apr 23
Additional proxy soliciting materials
7:44am
8-K
tfxzhliclup
10 Apr 23
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
7:45am
8-K
464men 1m
31 Mar 23
Tscan Therapeutics Announces Ceo Transition
8:57am
S-8
8m956alf9q
8 Mar 23
Registration of securities for employees
7:54am
8-K
f1ndx39i j0
8 Mar 23
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
7:15am